Pulmonary function after high-dose chemotherapy with autologous bone marrow transplantation and radiotherapy in patients with advanced loco-regional breast cancer

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 537-540

  Dolsma, Wil V ^a   De Vries, Elisabeth G E ^a   Van Der Mark, Thom W ^a   Sleijfer, Dirk Th ^a   Willemse, Pax H B ^a   Van Der Graaf, Winette T A ^a   Mulder, Paula O M ^a   Szabó, Ben G ^a   Mulder, Nanno H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Breast cancer; High dose chemotherapy; Pulmonary function; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; PREDNISONE; THIOTEPA; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG TOXICITY; LYMPH NODE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; SPIROMETRY; SYMPTOM; THORAX RADIOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MIDDLE AGED; RETROSPECTIVE STUDIES; VITAL CAPACITY;

EID: 0031059525     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mulder NH, Mulder POM, Sleijfer DTh, et al: Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. Eur J Cancer 29A: 668-672, 1993.
2. Peters WP, Ross M, Vredenburgh JJ, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11: 1132-1143, 1993.
3. De Graaf H, Willemse PHB, De Vries EGE, et al: Intensive chemotherapy with autologous bone marrow reinfusion in patients with breast cancer and more than five involved lymph nodes. Eur J Cancer 30A: 150-153, 1994.
4. Marks LB, Halperin EC, Prosnitz LR, et al: Post-mastectomy radiotherap) following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with more than ten positive axillary lymph nodes. Int J Rad Onc Biol Phys 23: 1021-1022, 1993.
5. Cotes JE: Lung function assessment and application in medicine. Oxford, Blackwell Scientific Publications, 1979, pp 235-244.
6. Cotes JE, Chin DJ, Quayer DJ, et al: Standardization of the measurement of Transfer Factor (Diffusing Capacity). E R J 6 (Suppl 16): 41-52, 1993.
7. Rothwell RI, Kelly SA, Joslin CAF: Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol 4: 9-14, 1985.
8. Rubin P, Casarett G: Respiratory System. In: Clinical Radiation Pathology (Saunders WB, ed.), Philadelphia, 1968, pp 423-440.
9. Gross NJ: Pulmonary effects of radiation therapy. Ann Intern Med 56:8192, 1977.
10. Hardman PDJ, Tweeddale PM, Kerr GR, et al: The effect of pulmonary function of local and loco-regional irradiation for breast cancer. Radiother Oncol 30: 33-42, 1994.
11. Rotstein S, Lax I, Svane G: Influence of radiation therapy on the lung-tissue in breast cancer patients: CT-assessed density changes and associated symptoms. Int J Rad Onc Biol Phys 18: 173-180, 1990.
12. Botterman J, Tasson J, Schelstraete K, et al: Scintigraphic, spirometric and rontgenologic effects of radiotherapy on normal lung tissue. Chest 97: 97-102, 1990.
13. Kreisman H, Wolkove N: Pulmonary toxicity of antineoplastic therapy. Sem Oncol 19: 508-520, 1992.
14. Finkelstein JN, Johnston CI, Baggs R, et al: Early alterations in extracellular matrix and transforming growth factor ß gene expression in mouse lung indicative of late radiation fibrosis. Int J Rad Onc Biol Phys 28: 621-631, 1994.
15. Anscher MS, Peters WP, Reisenbichler H, et al: Transforming growth factor ß as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328: 1592-1598, 1993.